Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 1 Trials

Scottsdale, Arizona

Phase 1 colorectal cancer trials in Scottsdale, AZ

13 Phase 1 colorectal cancer studies are recruiting participants at sites in Scottsdale as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.

Call (888) 415-5976
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Scottsdale at a glance

  • 13 studies are recruiting at a site in Scottsdale.
  • By phase: Phase 1 (6), Phase 1/2 (7).
  • By sponsor: industry (12), university, hospital or other (1).
  • Most recent update to one of these records: November 4, 2026.

Studies recruiting in Scottsdale

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    HonorHealth
    Registry record
    NCT06400472 · updated
  2. Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    Honor Health Research Institute
    Registry record
    NCT07397338 · updated
  3. A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    VM Discovery, Inc.
    Study site
    HonorHealth Research Institute (#600)
    Registry record
    NCT07636785 · updated
  4. This is a Phase 1/1b Study to Evaluate the Safety and Preliminary Antitumor Activity of LTZ-232 in Participants With Advanced/Metastatic Colorectal Cancer and Other Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    LTZ Therapeutics, Inc.
    Study site
    HonorHealth Research Institute
    Registry record
    NCT07878988 · updated
  5. A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Artios Pharma Ltd
    Study site
    Mayo Clinic (Arizona)
    Registry record
    NCT04657068 · updated
  6. A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    SHY Therapeutics
    Study site
    HonorHealth Research Institute
    Registry record
    NCT07705334 · updated
  7. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    Honor Health
    Registry record
    NCT05919264 · updated
  8. AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Avacta Life Sciences Ltd
    Study site
    Honor Health Research Institute
    Registry record
    NCT07454642 · updated
  9. Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Revolution Medicines, Inc.
    Study site
    HonorHealth Research Institute
    Registry record
    NCT06445062 · updated
  10. A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Seagen, a wholly owned subsidiary of Pfizer
    Study site
    Mayo Clinic
    Registry record
    NCT06131840 · updated
  11. Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    HonorHealth Research Institute
    Study site
    Clinical Trials Nurse Navigator
    Registry record
    NCT07463599 · updated
  12. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Clasp Therapeutics, Inc.
    Study site
    HonorHealth Research Institute
    Registry record
    NCT06778863 · updated
  13. A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    GI Innovation, Inc.
    Study site
    Mayo Clinic in Arizona
    Registry record
    NCT05824975 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Scottsdale, AZ on ClinicalTrials.gov.

Ask about studies near Scottsdale

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.

Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 415-5976

or send a short form

How should we reach you?

Call